Cryo Cell International (CCEL) Gross Margin (2010 - 2026)

Cryo Cell International has disclosed Gross Margin across 17 years of filings, most recently posting 78.44% for Q1 2026.

• In Q1 2026, Gross Margin rose 334.0% year-over-year to 78.44%; the TTM figure through Feb 2026 stood at 77.47% (up 168.0% YoY), while the FY2025 annual figure was 76.63%, up 148.0% from the prior year.
• Gross Margin climbed to 78.44% in Q1 2026, from 77.89% in the prior quarter.
• Over the last five years, Gross Margin for CCEL reached as high as 79.6% in Q4 2024 and fell as low as 69.42% in Q3 2022.
• The 5-year median for Gross Margin is 73.68% (2024), against an average of 74.34%.
• Annual changes were most pronounced in 2024 — Gross Margin soared 530 bps — and 2025, when it plunged 171 bps.
• A 5-year view of Gross Margin shows it stood at 72.45% in 2022, then gained by 3 bps to 74.31% in 2023, then climbed by 7 bps to 79.6% in 2024, then retreated by 2 bps to 77.89% in 2025, then gained by 1 bps to 78.44% in 2026.
• According to Business Quant data, Gross Margin over the past three periods registered 78.44%, 77.89%, and 76.98% for Q1 2026, Q4 2025, and Q3 2025 respectively.